Trials / Completed
CompletedNCT00542087
Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)
A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Etoricoxib 60 mg and Diclofenac Sodium 150 mg in Patient With Osteoarthritis of the Knee or Hip
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 516 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0663, etoricoxib / Duration of Treatment: 6 Weeks | |
| DRUG | Comparator: diclofenac sodium / Duration of Treatment: 6 Weeks |
Timeline
- Start date
- 2002-03-22
- Primary completion
- 2002-12-20
- Completion
- 2002-12-20
- First posted
- 2007-10-10
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00542087. Inclusion in this directory is not an endorsement.